Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.
Bladder cancer is the fifth most common cancer in the United States, and identifying genetic markers that may predict susceptibility in high-risk population is always needed. The purpose of our study is to determine whether genetic variations in the transforming growth factor-beta (TGF-β) pathway ar...
Main Authors: | Hua Wei, Ashish M Kamat, Saad Aldousari, Yuanqing Ye, Maosheng Huang, Colin P Dinney, Xifeng Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3520916?pdf=render |
Similar Items
-
Genetic variants in telomere-maintenance genes and bladder cancer risk.
by: Joshua Chang, et al.
Published: (2012-01-01) -
High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette–Guerin therapy: A long-term survival analysis
by: Kai Qu, et al.
Published: (2017-02-01) -
Genetic variations in glutathione pathway genes predict cancer recurrence in patients treated with trans-urethral resection and bacillus calmette-guerin instillation for non-muscle invasive bladder cancer
by: Hung-Lung Ke, MD, et al.
Published: (2015-06-01) -
Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin.
by: Hua Wei, et al.
Published: (2012-01-01) -
Bladder cancer: 2017 and beyond
by: Ashish M Kamat
Published: (2017-01-01)